SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-19-052968
Filing Date
2019-02-27
Accepted
2019-02-27 08:37:49
Documents
3

Document Format Files

Seq Description Document Type Size
1 POS AM d711458dposam.htm POS AM 533830
2 EX-23.1 d711458dex231.htm EX-23.1 1725
3 GRAPHIC g711458g57j37.jpg GRAPHIC 33539
  Complete submission text file 0001193125-19-052968.txt   582773
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-227814 | Film No.: 19635919
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences